PharmExec Direct:
Having trouble viewing this e-mail? Click here.
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
| Update My Profile | Advertise With Us | Visit PharmExec.com |
PRINT SUBSCRIBE | DIGITAL SUBSCRIBE
May 16, 2013 | ISSUE NUMBER 300 VOL 10

Patents
Medicines Patent Pool: Business Model of the Future?
At a time when Big Pharma is struggling with new business models geared to the demands of a changing marketplace, the Medicines Patent Pool is offering a way forward through voluntary licensing and patent deals that it insists will deliver what the drug majors say they want: more innovation; better market access; and the opportunity to demonstrate measurable improvements in public health ...Read more

CEO Compensation Data
Complete salary, bonus & market capitalization data in biotech.
www.bioworld.com

Patents
Is Indian Pharma Growth Doomed?
With the next wave of drugs coming off patent in the West set to stretch the India pharmaceutical industry beyond its limits, predictions for continued growth in the country may prove wildly optimistic, writes Chris Ward of World Health Advocacy ...Read More

The Waiting Game: Ways to Prepare for the AMP Final Rule
Live Webcast: Tuesday, June 4, 2013 from Noon to 1:00 PM Eastern
Register Free at www.pharmexec.com/ampfinal

Global
Read the New Pharm Exec Global Digest — Patents Special
In May’s issue: India’s Glivec Ruling — the Aftermath; Europe’s Unitary Patent — cause for excitement?; the UK Patent Box — will it hold delights for the industry? Also: a new era for UK’s NICE; smarter multichannel marketing; and more
...Read more

Marketing
Data: Is Bigger Always Better?
One of things that we’re hearing a lot about right now is big data. We’re told that we’re entering an era of big data that will come to transform business and government services alike. For data, so the thinking goes, the bigger the better. But, asks Agnitio’s Morten Hjelmsoe, is this always the case?
...Read more

Marketing
Pharm Exec’s What Physician’s Want Vol. I & II
How, when and why physicians consume information. Information on marketing, detailing, sampling, prescribing, CME, conventions and meetings from some of the best in the industry. Best methods to communicate with docs. New ideas from reorganization to alternative sales channels to embedded outsourcing
...Read more

// Venture capital company Third Rock Ventures (Boston, MA) appointed James Geraghty, formerly of Genzyme, as Entrepreneur-in-Residence, and recruited three new Venture Partners: Steven Paul, formerly President of Lilly Research Laboratories; Daniel Lynch, formerly CEO of ImClone Systems; and Alnylam’s CEO John Maraganore.//Stan Musial joined Egalet (Malvern, PA) as Chief Financial Officer.//Biopharm company Endocyte (West Lafayette, IN) appointed Dr Scot Harper as VP, Clinical Operations.//

June 4–5: 9th Medical Device and Diagnostics Compliance Congress
Washington, DC.


July 17–18: CBI’s Orphan Drug Information Summit
Philadelphia, PA.


August 19–21: 7th Annual Forum on Sunshine and Aggregate Spend
Washington DC.


 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook
Follow Pharm Exec on Linkedin


Survey
Has your department been downsized? If yes, by how much?

Click To Vote
Quick Links

Time to Catch on to Content Marketing

‘First Real European Patent’ Imminent

PhRMA Dismayed by Global IPR Report